Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.

Find out more.

News

  • May 30, 2013

    Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2013 Global Healthcare Conference

  • May 29, 2013

    Sucampo Appoints Kei Tolliver to Board of Directors

  • May 29, 2013

    Sucampo Pharmaceuticals Achieves Orphan Designation for Unoprostone Isopropyl for Treatment of Retinitis Pigmentosa by European Medicines Agency

  • May 15, 2013

    Sucampo to be Added to the NASDAQ Biotechnology Index